Skip to main content

Three pay to settle PFAS claims

8th June 2023

Submitted by:

Andrew Warmington

Chemours, DuPont and Corteva have reached an agreement in principle to resolve all per- and polyfluoroalkyl substance (PFAS)-related drinking water claims of a defined class of public water systems that serve “the vast majority of the US population”. They will pay about $592 million, $400 million and $193 million respectively into a settlement fund by 12 June.

This will conclude ongoing litigation on all water systems with a current detection of PFAS at any level and those that are currently required to monitor for the presence of PFAS under Environmental Protection Agency (EPA) rules or other applicable laws, including those in the South Carolina aqueous film-forming foam multi-district litigation. Not included in it are: water systems owned and operated by a state or the federal government; small systems that have not detected the presence of PFAS and are not subject to monitoring requirements; and those in the lower Cape Fear river basin of North Carolina, which can opt in if they wish.

This is all subject to final agreement, which is expected within Q2, and approval by the US District Court for the District of South Carolina. As part of this process, the court will establish a timetable for notice to class members, hearings on approval and for class members to opt out of the settlement. The companies will have the right to terminate the settlement if opt-outs exceed specified levels.

“If a settlement cannot be finalised and approved, and plaintiffs elect to pursue their claims in court, the companies will continue to assert their strong legal defenses in pending litigation,” they stated. They continue to deny the allegations in the underlying litigation.

The three companies have faced thousands of lawsuits in the US about the alleged effects of PFAS on human health and the environment. There has also been contention between them. Chemours, a DuPont spin-off, once sued its former parent over its legacy responsibilities for PFAS. Disagreement has also come to the surface again now with DuPont saying that it had never manufactured perfluorooctanoic acid (PFOA) or perfluorooctane sulfonic acid (PFOS). The other two denied this.

In May, Chemours became the first company in the US to be subject to an enforcement action for discharging PFAS from its Washington Works facility in Parkersburg, West Virginia, under the Clean Water Act. The EPA is now requiring it to implement a sampling plan analyse the release of PFAS and implement a plan to treat or minimise them.

The Washington Works discharges industrial process water and storm water to the Ohio River and its tributaries, under the terms of a state National Pollution Discharge Elimination System. This was issued in 2018 to replace one previously held by DuPont before the two companies were separated out.

Discharges exceeded those allowed in the Chemours permit on both PFOA and PFOS many times between 2018 and March 2023, even though PFOA is no longer used at the site and this is related to legacy emissions affecting groundwater. The firm said that it has worked with the EPA on a consent decree “and will continue to take action to address the legacy deposition that contributed to many of the exceedances”.

In June 2022, the EPA released four drinking water health advisories PFAS and announced that it would invited states and territories to apply for $1 billion through the Bipartisan Infrastructure Law to address PFAS and other emerging contaminants in drinking water, specifically in small or disadvantaged communities. The money can be spent on technical assistance, water quality testing, contractor training, and installing centralised treatment technologies and systems. A further $4 billion will become available later.

At the same time, the agency released updated health advisories on the basis of new evidence that “some negative health effects may occur with concentrations of PFOA or PFOS in water that are near zero and below EPA’s ability to detect at this time”. It also issued final health advisories for perfluorobutane sulfonic acid and its potassium salt (PFBS), which is used as a PFOS replacement in manufacturing; hexafluoropropylene oxide (HFPO), dimer acid and its ammonium salt, or GenX chemicals, which is used as an alternative to PFOS. The recommended levels are well above the level of detection, based on risk analyses in recent scientific studies.

Shortly after the settlement was announced, Chemours announced the resignation of CFO Sameer Ralhan and his replacement by Jonathan Lock, hitherto chief development officer. This has led to other changes, with Matt Abbott being named the company’s first Chief Enterprise Transformation Officer and Kristine Wellman, General Counsel and Corporate Secretary, taking charge of the Sustainability organization from Lock.

(Lock himself was integral to the recent decision by Chemours to sell its glycolic acid business to PureTech Scientific for $137 million. This is expected to close in Q3, subject to regulatory approvals and other customary closing conditions. PureTech, which is owned by private equity firm Iron Path Capital, seeks to the global leader in organic synthesis of ultra-high purity alpha-hydroxy acids for life sciences and speciality chemicals.)

It is not clear if there is any link between Ralhan’s departure and the ongoing PFAS problems but this is just the latest in a line of senior executives to leave Chemours. The presidents of the Titanium Technologies & Chemical Solutions and Thermal & Specialized Solutions, Edwin Sparks and Alisha Bellezza, left in March and May respectively. Both jobs are being covered on an interim basis while replacements are sought.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington